| Trade Date |
Insider |
Title |
Buy or Sell |
Quantity |
Security Type |
Price |
Proceeds |
Transaction Conviction |
Position Quantity |
Position Value |
Positon Conviction |
SEC Link |
Nature of Ownership |
2020-07-01 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 10,795,348 | $0.00 | - | Form 4 | Footnote | 2020-07-01 | Partners, L.p. Broadwood | - | Sell | 4,062 | Common Stock | $0.00 | $0.00 | - | 10,795,348 | $0.00 | - | Form 4 | - | 2020-05-15 | Keith Holliday | Chief Technology Officer | Buy | 25,000 | Common Stock | $7.20 | -$180,000.00 | 5.49 [ Very High ] | 53,447 | $384,818.40 | 11.74 [Average] | Form 4 | - | 2020-05-15 | Keith Holliday | Chief Technology Officer | Sell | 25,000 | Common Stock | $37.69 | $942,250.00 | 5.49 [ Very High ] | 28,447 | $1,072,167.43 | 6.25 [Average] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000 | Common Stock | $5.34 | -$106,800.00 | 4.39 [ Very High ] | 61,185 | $326,727.90 | 13.44 [Average] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000 | Common Stock | $7.35 | -$147,000.00 | 4.39 [ Very High ] | 81,185 | $596,709.75 | 17.84 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000 | Common Stock | $7.52 | -$150,400.00 | 4.39 [ Very High ] | 101,185 | $760,911.20 | 22.23 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 21,875 | Common Stock | $9.30 | -$203,437.50 | 4.81 [ Very High ] | 123,060 | $1,144,458.00 | 27.04 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 50,000 | Common Stock | $11.02 | -$551,000.00 | 10.99 [ Very High ] | 173,060 | $1,907,121.20 | 38.02 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000 | Common Stock | $11.02 | -$220,400.00 | 4.39 [ Very High ] | 193,060 | $2,127,521.20 | 42.42 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 12,500 | Common Stock | $15.54 | -$194,250.00 | 2.75 [ Very High ] | 205,560 | $3,194,402.40 | 45.16 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 13,333 | Common Stock | $16.50 | -$219,994.50 | 2.93 [ Very High ] | 218,893 | $3,611,734.50 | 48.09 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 6,292 | Common Stock | $29.80 | -$187,501.60 | 1.38 [ High ] | 225,185 | $6,710,513.00 | 49.47 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 8,522 | Common Stock | $35.98 | -$306,621.56 | 1.87 [ High ] | 233,707 | $8,408,777.86 | 51.35 [High] | Form 4 | - | 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Sell | 192,522 | Common Stock | $40.00 | $7,700,880.00 | 42.30 [ Very High ] | 41,185 | $1,647,400.00 | 9.05 [Average] | Form 4 | - | 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 8,000 | Common Stock | $7.35 | -$58,800.00 | 1.76 [ High ] | 52,466 | $385,625.10 | 11.53 [Average] | Form 4 | - | 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 10,856 | Common Stock | $15.54 | -$168,702.24 | 2.39 [ Very High ] | 63,322 | $984,023.88 | 13.91 [Average] | Form 4 | - | 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 18,856 | Common Stock | $39.06 | $736,515.36 | 4.14 [ Very High ] | 44,466 | $1,736,841.96 | 9.77 [Average] | Form 4 | - | 2020-05-13 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 6,667 | Common Stock | $5.34 | -$35,601.78 | 1.46 [ High ] | 51,133 | $273,050.22 | 11.23 [Average] | Form 4 | - | 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 21,294 | Common Stock | $9.30 | -$198,034.20 | 4.68 [ Very High ] | 32,088 | $298,418.40 | 7.05 [Average] | Form 4 | - | 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 19,178 | Common Stock | $7.52 | -$144,218.56 | 4.21 [ Very High ] | 51,266 | $385,520.32 | 11.26 [Average] | Form 4 | - | 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 6,091 | Common Stock | $8.64 | -$52,626.24 | 1.34 [ High ] | 57,357 | $495,564.48 | 12.60 [Average] | Form 4 | - | 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 46,563 | Common Stock | $39.11 | $1,821,078.93 | 10.23 [ Very High ] | 10,794 | $422,153.34 | 2.37 [Low] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 3,437 | Common Stock | $39.02 | $134,111.74 | 0.76 [ High ] | 16,022 | $625,178.44 | 3.52 [Low] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 6,741 | Common Stock | $9.30 | -$62,691.30 | 1.48 [ High ] | 22,763 | $211,695.90 | 5.00 [Average] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 2,860 | Common Stock | $39.04 | $111,654.40 | 0.63 [ Average ] | 19,903 | $777,013.12 | 4.37 [Low] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 4,862 | Common Stock | $15.25 | -$74,145.50 | 1.07 [ High ] | 24,765 | $377,666.25 | 5.44 [Average] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 3,473 | Common Stock | $39.02 | $135,516.46 | 0.76 [ High ] | 21,292 | $830,813.84 | 4.68 [Average] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 8,680 | Common Stock | $16.15 | -$140,182.00 | 1.91 [ High ] | 29,972 | $484,047.80 | 6.59 [Average] | Form 4 | - | 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 8,419 | Common Stock | $39.01 | $328,425.19 | 1.85 [ High ] | 21,553 | $840,782.53 | 4.74 [Average] | Form 4 | - | 2020-06-01 | Gilbert H Kliman | - | Buy | 464 | Common Stock | $0.00 | $0.00 | - | 464 | $0.00 | - | Form 4 | - | 2020-06-10 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 785 | Common Stock | $11.00 | -$8,635.00 | - | 128,735 | $1,416,085.00 | - | Form 4 | - | 2020-06-10 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 785 | Common Stock | $44.00 | $34,540.00 | - | 127,950 | $5,629,800.00 | - | Form 4 | - | 2020-06-15 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 19,215 | Common Stock | $11.00 | -$211,365.00 | - | 147,165 | $1,618,815.00 | - | Form 4 | - | 2020-06-15 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 20,000 | Common Stock | $5.34 | -$106,800.00 | - | 167,165 | $892,661.10 | - | Form 4 | - | 2020-06-15 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 39,215 | Common Stock | $44.07 | $1,728,205.05 | - | 127,950 | $5,638,756.50 | - | Form 4 | - | 2020-07-30 | Stephen C Farrell | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 5,808 | $0.00 | 1.28 [Low] | Form 4 | - | 2020-07-30 | Lou Silverman | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 15,850 | $0.00 | 3.48 [Low] | Form 4 | - | 2020-07-30 | Gilbert H Kliman | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 2,581 | $0.00 | 0.57 [Very Low] | Form 4 | - | 2020-07-30 | John C Moore | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 2,117 | $0.00 | 0.47 [Very Low] | Form 4 | - | 2020-07-30 | Thomas G Frinzi | - | Buy | 2,117 | Common Stock | $0.00 | $0.00 | - | 2,117 | $0.00 | 0.47 [Very Low] | Form 4 | - | 2020-08-10 | Patrick F. Williams | Chief Financial Officer | Buy | 30,727 | Common Stock | $0.00 | $0.00 | - | 30,727 | $0.00 | 6.71 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 16,206 | Common Stock | $9.30 | -$150,715.80 | 3.54 [ Very High ] | 27,000 | $251,100.00 | 5.89 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 5,822 | Common Stock | $7.52 | -$43,781.44 | 1.27 [ High ] | 32,822 | $246,821.44 | 7.17 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 11,574 | Common Stock | $8.64 | -$99,999.36 | 2.53 [ Very High ] | 44,396 | $383,581.44 | 9.69 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 8,000 | Common Stock | $16.15 | -$129,200.00 | 1.75 [ High ] | 52,396 | $846,195.40 | 11.44 [Average] | Form 4 | - | 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 41,602 | Common Stock | $51.22 | $2,130,854.44 | 9.08 [ Very High ] | 10,794 | $552,868.68 | 2.36 [Low] | Form 4 | - | 2020-09-09 | John C Moore | - | Sell | 137,331 | Common Stock | $52.04 | $7,146,705.24 | 29.98 [ Very High ] | 21,387 | $1,112,979.48 | 4.67 [Low] | Form 4 | By Family Trust | 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 1,286 | Common Stock | $7.52 | -$9,670.72 | 0.28 [ Low ] | 29,733 | $223,592.16 | 6.49 [Average] | Form 4 | - | 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 21,294 | Common Stock | $9.30 | -$198,034.20 | 4.65 [ Very High ] | 51,027 | $474,551.10 | 11.14 [Average] | Form 4 | - | 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 3,994 | Common Stock | $16.15 | -$64,503.10 | 0.87 [ High ] | 55,021 | $888,589.15 | 12.01 [Average] | Form 4 | - | 2020-09-14 | Keith Holliday | Chief Technology Officer | Sell | 26,574 | Common Stock | $53.26 | $1,415,331.24 | 5.80 [ Very High ] | 28,447 | $1,515,087.22 | 6.21 [Average] | Form 4 | - | 2020-09-14 | Keith Holliday | Chief Technology Officer | Sell | 9,115 | Common Stock | $53.49 | $487,561.35 | 1.99 [ High ] | 19,332 | $1,034,068.68 | 4.22 [Low] | Form 4 | - | 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 13,217 | Common Stock | $16.15 | -$213,454.55 | 2.89 [ Very High ] | 32,549 | $525,666.35 | 7.11 [Average] | Form 4 | - | 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 10,112 | Common Stock | $29.80 | -$301,337.60 | 2.21 [ High ] | 42,661 | $1,271,297.80 | 9.31 [Average] | Form 4 | - | 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 12,997 | Common Stock | $35.98 | -$467,632.06 | 2.84 [ Very High ] | 55,658 | $2,002,574.84 | 12.15 [Average] | Form 4 | - | 2020-09-15 | Keith Holliday | Chief Technology Officer | Sell | 36,326 | Common Stock | $53.33 | $1,937,265.58 | 7.93 [ Very High ] | 19,332 | $1,030,975.56 | 4.22 [Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Buy | 5,000 | Common Stock | $10.31 | -$51,550.00 | 1.08 [ High ] | 7,117 | $73,376.27 | 1.54 [Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Buy | 10,000 | Common Stock | $15.73 | -$157,300.00 | 2.17 [ High ] | 17,117 | $269,250.41 | 3.71 [Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Buy | 1,206 | Common Stock | $16.15 | -$19,476.90 | 0.26 [ Low ] | 18,323 | $295,916.45 | 3.97 [Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Sell | 16,206 | Common Stock | $81.03 | $1,313,172.18 | 3.51 [ Very High ] | 2,117 | $171,540.51 | 0.46 [Very Low] | Form 4 | - | 2020-11-09 | John C Moore | - | Sell | 14,254 | Common Stock | $80.88 | $1,152,863.52 | 3.09 [ Very High ] | 11,387 | $920,980.56 | 2.47 [Low] | Form 4 | By Family Trust | 2020-11-09 | Keith Holliday | Chief Technology Officer | Buy | 23,714 | Common Stock | $7.52 | -$178,329.28 | 5.14 [ Very High ] | 43,046 | $323,705.92 | 9.34 [Average] | Form 4 | - | 2020-11-09 | Keith Holliday | Chief Technology Officer | Buy | 15,000 | Common Stock | $9.30 | -$139,500.00 | 3.25 [ Very High ] | 58,046 | $539,827.80 | 12.59 [Average] | Form 4 | - | 2020-11-09 | Keith Holliday | Chief Technology Officer | Sell | 23,714 | Common Stock | $81.56 | $1,934,113.84 | 5.14 [ Very High ] | 34,332 | $2,800,117.92 | 7.45 [Average] | Form 4 | - | 2020-11-09 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 10,200 | Common Stock | $29.80 | -$303,960.00 | 2.21 [ High ] | 20,994 | $625,621.20 | 4.55 [Low] | Form 4 | - | 2020-11-09 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 9,800 | Common Stock | $16.15 | -$158,270.00 | 2.13 [ High ] | 30,794 | $497,323.10 | 6.68 [Average] | Form 4 | - | 2020-11-09 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 20,000 | Common Stock | $81.34 | $1,626,800.00 | 4.34 [ Very High ] | 10,794 | $877,983.96 | 2.34 [Low] | Form 4 | - | 2020-11-16 | Scott D Barnes | Chief Medical Officer | Buy | 5,430 | Common Stock | $29.80 | -$161,814.00 | 1.18 [ High ] | 25,820 | $769,436.00 | 5.60 [Average] | Form 4 | - | 2020-11-16 | Scott D Barnes | Chief Medical Officer | Buy | 17,163 | Common Stock | $35.98 | -$617,524.74 | 3.72 [ Very High ] | 42,983 | $1,546,528.34 | 9.32 [Average] | Form 4 | - | 2020-11-16 | Scott D Barnes | Chief Medical Officer | Sell | 22,593 | Common Stock | $80.25 | $1,813,088.25 | 4.90 [ Very High ] | 20,390 | $1,636,297.50 | 4.42 [Low] | Form 4 | - | 2020-11-19 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 12,156 | Common Stock | $15.54 | -$188,904.24 | 2.64 [ Very High ] | 140,106 | $2,177,247.24 | 30.39 [High] | Form 4 | - | 2020-11-19 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 12,156 | Common Stock | $82.02 | $997,035.12 | 2.64 [ Very High ] | 127,950 | $10,494,459.00 | 27.75 [High] | Form 4 | - | 2020-11-19 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 14,007 | Common Stock | $82.03 | $1,148,994.21 | 3.04 [ Very High ] | 113,943 | $9,346,744.29 | 24.71 [High] | Form 4 | - | 2020-11-20 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 2,688 | Common Stock | $83.02 | $223,157.76 | 0.58 [ Average ] | 111,255 | $9,236,390.10 | 24.13 [High] | Form 4 | - | 2020-11-23 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 1,900 | Common Stock | $15.54 | -$29,526.00 | 0.41 [ Average ] | 113,155 | $1,758,428.70 | 24.54 [High] | Form 4 | - | 2020-11-23 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 1,900 | Common Stock | $83.02 | $157,738.00 | 0.41 [ Average ] | 111,255 | $9,236,390.10 | 24.13 [High] | Form 4 | - | 2020-11-23 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 2,874 | Common Stock | $83.14 | $238,944.36 | 0.62 [ Average ] | 108,381 | $9,010,796.34 | 23.50 [High] | Form 4 | - | 2020-11-23 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 14,815 | Common Stock | $7.35 | -$108,890.25 | 3.21 [ Very High ] | 66,198 | $486,555.30 | 14.36 [Average] | Form 4 | - | 2020-11-23 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 4,144 | Common Stock | $15.54 | -$64,397.76 | 0.90 [ High ] | 70,342 | $1,093,114.68 | 15.26 [Average] | Form 4 | - | 2020-11-23 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 18,959 | Common Stock | $80.13 | $1,519,184.67 | 4.11 [ Very High ] | 51,383 | $4,117,319.79 | 11.14 [Average] | Form 4 | - | 2021-01-04 | Partners, L.p. Broadwood | - | Sell | 45,443 | Common Stock | $0.00 | $0.00 | - | 10,749,905 | $0.00 | 2,331.36 [Very High] | Form 4 | - | 2021-01-04 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 10,749,905 | $0.00 | 2,331.36 [Very High] | Form 4 | Footnote | 2021-01-12 | Partners, L.p. Broadwood | - | Sell | 60,000 | Common Stock | $89.28 | $5,356,800.00 | 13.01 [ Very High ] | 10,689,905 | $954,394,718.40 | 2,318.35 [Very High] | Form 4 | - | 2021-01-12 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 10,689,905 | $0.00 | 2,318.35 [Very High] | Form 4 | Footnote | 2020-01-21 | K Peony Yu | - | Buy | 318 | Common Stock | $0.00 | $0.00 | - | 318 | $0.00 | 0.07 [Very Low] | Form 4 | - | 2021-01-26 | Partners, L.p. Broadwood | - | Sell | 347,000 | Common Stock | $102.33 | $35,508,510.00 | 75.25 [ Very High ] | 10,342,905 | $1,058,389,468.65 | 2,243.09 [Very High] | Form 4 | - | 2021-01-26 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 10,342,905 | $0.00 | 2,243.09 [Very High] | Form 4 | Footnote | 2021-01-27 | Partners, L.p. Broadwood | - | Sell | 164,686 | Common Stock | $103.99 | $17,125,697.14 | 35.72 [ Very High ] | 10,178,219 | $1,058,432,993.81 | 2,207.38 [Very High] | Form 4 | - | 2021-01-27 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 10,178,219 | $0.00 | 2,207.38 [Very High] | Form 4 | Footnote | 2021-01-28 | Partners, L.p. Broadwood | - | Sell | 278,197 | Common Stock | $105.83 | $29,441,588.51 | 60.33 [ Very High ] | 9,900,022 | $1,047,719,328.26 | 2,147.04 [Very High] | Form 4 | - | 2021-01-28 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,900,022 | $0.00 | 2,147.04 [Very High] | Form 4 | Footnote | 2021-02-02 | Partners, L.p. Broadwood | - | Sell | 1,589 | Common Stock | $110.32 | $175,298.48 | 0.34 [ Average ] | 9,898,433 | $1,091,995,128.56 | 2,146.70 [Very High] | Form 4 | - | 2021-02-02 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,898,433 | $0.00 | 2,146.70 [Very High] | Form 4 | Footnote | 2021-02-03 | Partners, L.p. Broadwood | - | Sell | 10,585 | Common Stock | $110.44 | $1,169,007.40 | 2.30 [ High ] | 9,887,848 | $1,092,013,933.12 | 2,144.40 [Very High] | Form 4 | - | 2021-02-03 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,887,848 | $0.00 | 2,144.40 [Very High] | Form 4 | Footnote | 2021-02-04 | Partners, L.p. Broadwood | - | Sell | 48,687 | Common Stock | $111.15 | $5,411,560.05 | 10.56 [ Very High ] | 9,839,161 | $1,093,622,745.15 | 2,133.85 [Very High] | Form 4 | - | 2021-02-04 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,839,161 | $0.00 | 2,133.85 [Very High] | Form 4 | Footnote | 2021-02-05 | Partners, L.p. Broadwood | - | Sell | 47,700 | Common Stock | $116.09 | $5,537,493.00 | 10.34 [ Very High ] | 9,791,461 | $1,136,690,707.49 | 2,123.50 [Very High] | Form 4 | - | 2021-02-05 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,791,461 | $0.00 | 2,123.50 [Very High] | Form 4 | Footnote | 2021-02-08 | Partners, L.p. Broadwood | - | Sell | 144,838 | Common Stock | $122.28 | $17,710,790.64 | 31.41 [ Very High ] | 9,646,623 | $1,179,589,060.44 | 2,092.09 [Very High] | Form 4 | - | 2021-02-08 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,646,623 | $0.00 | 2,092.09 [Very High] | Form 4 | Footnote | 2021-02-09 | Partners, L.p. Broadwood | - | Sell | 65,081 | Common Stock | $124.09 | $8,075,901.29 | 14.11 [ Very High ] | 9,581,542 | $1,188,973,546.78 | 2,077.97 [Very High] | Form 4 | - | 2021-02-09 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,581,542 | $0.00 | 2,077.97 [Very High] | Form 4 | Footnote | 2021-02-10 | Partners, L.p. Broadwood | - | Sell | 7,789 | Common Stock | $124.90 | $972,846.10 | 1.69 [ High ] | 9,573,753 | $1,195,761,749.70 | 2,076.29 [Very High] | Form 4 | - | 2021-02-10 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,573,753 | $0.00 | 2,076.29 [Very High] | Form 4 | Footnote | 2021-02-11 | Partners, L.p. Broadwood | - | Sell | 7,412 | Common Stock | $124.51 | $922,868.12 | 1.61 [ High ] | 9,566,341 | $1,191,105,117.91 | 2,074.68 [Very High] | Form 4 | - | 2021-02-11 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,566,341 | $0.00 | 2,074.68 [Very High] | Form 4 | Footnote | 2021-02-12 | Partners, L.p. Broadwood | - | Sell | 22,250 | Common Stock | $124.22 | $2,763,895.00 | 4.83 [ Very High ] | 9,544,091 | $1,185,566,984.02 | 2,069.85 [Very High] | Form 4 | - | 2021-02-12 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,544,091 | $0.00 | 2,069.85 [Very High] | Form 4 | Footnote | 2021-03-01 | Lou Silverman | - | Sell | 23,996 | Common Stock | $104.78 | $2,514,300.88 | 5.15 [ Very High ] | 2,117 | $221,819.26 | 0.45 [Very Low] | Form 4 | - | 2021-03-01 | Caren L Mason | President & CEO | Buy | 45,000 | Common Stock | $7.76 | -$349,200.00 | 9.66 [ Very High ] | 89,013 | $690,740.88 | 19.12 [High] | Form 4 | - | 2021-03-01 | Caren L Mason | President & CEO | Sell | 45,000 | Common Stock | $104.76 | $4,714,200.00 | 9.66 [ Very High ] | 44,013 | $4,610,801.88 | 9.45 [Average] | Form 4 | - | 2021-03-02 | Caren L Mason | President & CEO | Buy | 45,000 | Common Stock | $7.76 | -$349,200.00 | 9.66 [ Very High ] | 89,013 | $690,740.88 | 19.12 [High] | Form 4 | - | 2021-03-02 | Caren L Mason | President & CEO | Sell | 45,000 | Common Stock | $103.53 | $4,658,850.00 | 9.66 [ Very High ] | 44,013 | $4,556,665.89 | 9.45 [Average] | Form 4 | - | 2021-03-03 | Caren L Mason | President & CEO | Buy | 45,000 | Common Stock | $7.76 | -$349,200.00 | 9.66 [ Very High ] | 89,013 | $690,740.88 | 19.12 [High] | Form 4 | - | 2021-03-03 | Caren L Mason | President & CEO | Sell | 45,000 | Common Stock | $98.32 | $4,424,400.00 | 9.66 [ Very High ] | 44,013 | $4,327,358.16 | 9.45 [Average] | Form 4 | - | 2021-03-01 | Keith Holliday | Chief Technology Officer | Sell | 5,208 | Common Stock | $103.85 | $540,850.80 | 1.12 [ High ] | 29,124 | $3,024,527.40 | 6.25 [Average] | Form 4 | - | 2021-03-01 | Keith Holliday | Chief Technology Officer | Buy | 1,206 | Common Stock | $9.30 | -$11,215.80 | 0.26 [ Low ] | 30,330 | $282,069.00 | 6.51 [Average] | Form 4 | - | 2021-03-01 | Keith Holliday | Chief Technology Officer | Buy | 7,094 | Common Stock | $16.15 | -$114,568.10 | 1.52 [ High ] | 37,424 | $604,397.60 | 8.04 [Average] | Form 4 | - | 2021-03-01 | Keith Holliday | Chief Technology Officer | Buy | 1,873 | Common Stock | $29.80 | -$55,815.40 | 0.40 [ Average ] | 39,297 | $1,171,050.60 | 8.44 [Average] | Form 4 | - | 2021-03-01 | Keith Holliday | Chief Technology Officer | Buy | 3,610 | Common Stock | $35.98 | -$129,887.80 | 0.78 [ High ] | 42,907 | $1,543,793.86 | 9.21 [Average] | Form 4 | - | 2021-03-01 | Keith Holliday | Chief Technology Officer | Sell | 13,783 | Common Stock | $104.82 | $1,444,734.06 | 2.96 [ Very High ] | 29,124 | $3,052,777.68 | 6.25 [Average] | Form 4 | - | 2021-03-01 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 16,000 | Common Stock | $35.98 | -$575,680.00 | 3.44 [ Very High ] | 26,794 | $964,048.12 | 5.75 [Average] | Form 4 | - | 2021-03-01 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 16,000 | Common Stock | $105.43 | $1,686,880.00 | 3.44 [ Very High ] | 10,794 | $1,138,011.42 | 2.32 [Low] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 2,431 | Common Stock | $15.25 | -$37,072.75 | 0.52 [ Average ] | 23,984 | $365,756.00 | 5.15 [Average] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 1,218 | Common Stock | $16.15 | -$19,670.70 | 0.26 [ Low ] | 25,202 | $407,012.30 | 5.41 [Average] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 374 | Common Stock | $29.80 | -$11,145.20 | 0.08 [ Very Low ] | 25,546 | $761,270.80 | 5.49 [Average] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 229 | Common Stock | $35.98 | -$8,239.42 | 0.05 [ Very Low ] | 25,805 | $928,463.90 | 5.54 [Average] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 5,618 | Common Stock | $29.80 | -$167,416.40 | 1.21 [ High ] | 31,423 | $936,405.40 | 6.75 [Average] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 14,491 | Common Stock | $35.98 | -$521,386.18 | 3.11 [ Very High ] | 45,914 | $1,651,985.72 | 9.86 [Average] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 185 | Common Stock | $16.15 | -$2,987.75 | 0.04 [ Very Low ] | 46,099 | $744,498.85 | 9.90 [Average] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 20,294 | Common Stock | $103.21 | $2,094,543.74 | 4.36 [ Very High ] | 25,805 | $2,663,334.05 | 5.54 [Average] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 11,427 | Common Stock | $103.05 | $1,177,552.35 | 2.45 [ Very High ] | 14,378 | $1,481,652.90 | 3.09 [Low] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 2,069 | Common Stock | $16.15 | -$33,414.35 | 0.44 [ Average ] | 16,447 | $265,619.05 | 3.53 [Low] | Form 4 | - | 2021-03-01 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 2,069 | Common Stock | $106.03 | $219,376.07 | 0.44 [ Average ] | 14,378 | $1,524,499.34 | 3.09 [Low] | Form 4 | - | 2021-03-09 | Scott D Barnes | Chief Medical Officer | Buy | 4,800 | Common Stock | $16.15 | -$77,520.00 | 1.03 [ High ] | 25,190 | $406,818.50 | 5.41 [Average] | Form 4 | - | 2021-03-09 | Scott D Barnes | Chief Medical Officer | Buy | 188 | Common Stock | $29.80 | -$5,602.40 | 0.04 [ Very Low ] | 25,378 | $756,264.40 | 5.45 [Average] | Form 4 | - | 2021-03-09 | Scott D Barnes | Chief Medical Officer | Buy | 2,345 | Common Stock | $35.98 | -$84,373.10 | 0.50 [ Average ] | 27,723 | $997,473.54 | 5.95 [Average] | Form 4 | - | 2021-03-09 | Scott D Barnes | Chief Medical Officer | Sell | 3,300 | Common Stock | $88.48 | $291,984.00 | 0.71 [ Average ] | 24,423 | $2,160,947.04 | 5.24 [Average] | Form 4 | - | 2021-03-09 | Scott D Barnes | Chief Medical Officer | Sell | 4,033 | Common Stock | $89.25 | $359,945.25 | 0.87 [ High ] | 20,390 | $1,819,807.50 | 4.38 [Low] | Form 4 | - | 2021-03-12 | Caren L Mason | President & CEO | Buy | 19,363 | Common Stock | $0.00 | $0.00 | - | 63,376 | $0.00 | 13.61 [Average] | Form 4 | - | 2021-03-12 | Samuel J Gesten | Chief Legal Officer | Buy | 2,430 | Common Stock | $0.00 | $0.00 | - | 43,615 | $0.00 | 9.37 [Average] | Form 4 | - | 2021-03-12 | Patrick F. Williams | Chief Financial Officer | Buy | 2,513 | Common Stock | $0.00 | $0.00 | - | 33,240 | $0.00 | 7.14 [Average] | Form 4 | - | 2021-03-12 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 2,169 | Common Stock | $0.00 | $0.00 | - | 53,552 | $0.00 | 11.50 [Average] | Form 4 | - | 2021-03-12 | Keith Holliday | Chief Technology Officer | Buy | 2,471 | Common Stock | $0.00 | $0.00 | - | 31,595 | $0.00 | 6.79 [Average] | Form 4 | - | 2021-03-11 | Scott D Barnes | Chief Medical Officer | Buy | 2,665 | Common Stock | $15.25 | -$40,641.25 | 0.57 [ Average ] | 23,055 | $351,588.75 | 4.95 [Average] | Form 4 | - | 2021-03-11 | Scott D Barnes | Chief Medical Officer | Sell | 2,665 | Common Stock | $92.00 | $245,180.00 | 0.57 [ Average ] | 20,390 | $1,875,880.00 | 4.38 [Low] | Form 4 | - | 2021-03-12 | Scott D Barnes | Chief Medical Officer | Buy | 2,936 | Common Stock | $0.00 | $0.00 | - | 23,326 | $0.00 | 5.01 [Average] | Form 4 | - | 2021-03-16 | Scott D Barnes | Chief Medical Officer | Buy | 2,664 | Common Stock | $15.25 | -$40,626.00 | 0.57 [ Average ] | 23,054 | $351,573.50 | 4.95 [Average] | Form 4 | - | 2021-03-16 | Scott D Barnes | Chief Medical Officer | Sell | 2,664 | Common Stock | $95.00 | $253,080.00 | 0.57 [ Average ] | 20,390 | $1,937,050.00 | 4.38 [Low] | Form 4 | - | 2021-03-22 | Samuel J Gesten | Chief Legal Officer | Sell | 1,032 | Common Stock | $96.37 | $99,453.84 | 0.22 [ Low ] | 42,583 | $4,103,723.71 | 9.14 [Average] | Form 4 | - | 2021-03-22 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 922 | Common Stock | $96.37 | $88,853.14 | 0.20 [ Low ] | 52,630 | $5,071,953.10 | 11.30 [Average] | Form 4 | - | 2021-03-22 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 1,103 | Common Stock | $96.37 | $106,296.11 | 0.24 [ Low ] | 9,691 | $933,921.67 | 2.08 [Low] | Form 4 | - | 2021-04-01 | Partners, L.p. Broadwood | - | Sell | 100,000 | Common Stock | $0.00 | $0.00 | - | 9,444,091 | $0.00 | 2,028.15 [Very High] | Form 4 | - | 2021-04-01 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,444,091 | $0.00 | 2,028.15 [Very High] | Form 4 | Footnote | 2021-04-22 | Partners, L.p. Broadwood | - | Sell | 20,669 | Common Stock | $130.34 | $2,693,997.46 | 4.44 [ Very High ] | 9,423,422 | $1,228,248,823.48 | 2,023.71 [Very High] | Form 4 | - | 2021-04-22 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,423,422 | $0.00 | 2,023.71 [Very High] | Form 4 | See Footnote | 2021-04-23 | Partners, L.p. Broadwood | - | Sell | 53,854 | Common Stock | $133.51 | $7,190,047.54 | 11.57 [ Very High ] | 9,369,568 | $1,250,931,023.68 | 2,012.15 [Very High] | Form 4 | - | 2021-04-23 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,369,568 | $0.00 | 2,012.15 [Very High] | Form 4 | See Footnote | 2021-04-26 | Partners, L.p. Broadwood | - | Sell | 43,383 | Common Stock | $135.30 | $5,869,719.90 | 9.32 [ Very High ] | 9,326,185 | $1,261,832,830.50 | 2,002.83 [Very High] | Form 4 | - | 2021-04-26 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,326,185 | $0.00 | 2,002.83 [Very High] | Form 4 | See Footnote | 2021-05-10 | Caren L Mason | President & CEO | Buy | 53,500 | Common Stock | $7.76 | -$415,160.00 | 11.41 [ Very High ] | 116,876 | $906,957.76 | 24.92 [High] | Form 4 | - | 2021-05-10 | Caren L Mason | President & CEO | Sell | 53,500 | Common Stock | $119.88 | $6,413,580.00 | 11.41 [ Very High ] | 63,376 | $7,597,514.88 | 13.51 [Average] | Form 4 | - | 2021-05-11 | Caren L Mason | President & CEO | Buy | 53,500 | Common Stock | $7.76 | -$415,160.00 | 11.41 [ Very High ] | 116,876 | $906,957.76 | 24.92 [High] | Form 4 | - | 2021-05-11 | Caren L Mason | President & CEO | Sell | 53,500 | Common Stock | $110.70 | $5,922,450.00 | 11.41 [ Very High ] | 63,376 | $7,015,723.20 | 13.51 [Average] | Form 4 | - | 2021-05-10 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 2,158 | Common Stock | $7.35 | -$15,861.30 | 0.46 [ Average ] | 54,788 | $402,691.80 | 11.68 [Average] | Form 4 | - | 2021-05-10 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 9,425 | Common Stock | $7.52 | -$70,876.00 | 2.01 [ High ] | 64,213 | $482,881.76 | 13.69 [Average] | Form 4 | - | 2021-05-10 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 11,583 | Common Stock | $125.72 | $1,456,214.76 | 2.47 [ Very High ] | 52,630 | $6,616,643.60 | 11.22 [Average] | Form 4 | - | 2021-05-10 | Keith Holliday | Chief Technology Officer | Sell | 8,874 | Common Stock | $125.83 | $1,116,615.42 | 1.89 [ High ] | 22,721 | $2,858,983.43 | 4.85 [Average] | Form 4 | - | 2021-05-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 1,349 | Common Stock | $125.22 | $168,921.78 | 0.29 [ Average ] | 8,342 | $1,044,585.24 | 1.78 [Low] | Form 4 | - | 2021-05-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 7,200 | Common Stock | $16.15 | -$116,280.00 | 1.54 [ High ] | 15,542 | $251,003.30 | 3.31 [Low] | Form 4 | - | 2021-05-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 2,534 | Common Stock | $29.80 | -$75,513.20 | 0.54 [ Average ] | 18,076 | $538,664.80 | 3.85 [Low] | Form 4 | - | 2021-05-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 3,462 | Common Stock | $35.98 | -$124,562.76 | 0.74 [ Average ] | 21,538 | $774,937.24 | 4.59 [Average] | Form 4 | - | 2021-05-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 5,523 | Common Stock | $27.53 | -$152,048.19 | 1.18 [ High ] | 27,061 | $744,989.33 | 5.77 [Average] | Form 4 | - | 2021-05-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 10,760 | Common Stock | $124.13 | $1,335,638.80 | 2.29 [ High ] | 16,301 | $2,023,443.13 | 3.48 [Low] | Form 4 | - | 2021-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 1,050 | Common Stock | $35.98 | -$37,779.00 | 0.22 [ Low ] | 15,428 | $555,099.44 | 3.29 [Low] | Form 4 | - | 2021-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 10,025 | Common Stock | $27.53 | -$275,988.25 | 2.14 [ High ] | 25,453 | $700,721.09 | 5.43 [Average] | Form 4 | - | 2021-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 11,075 | Common Stock | $111.61 | $1,236,080.75 | 2.36 [ High ] | 14,378 | $1,604,728.58 | 3.07 [Low] | Form 4 | - | 2021-05-12 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 5,531 | Common Stock | $110.74 | $612,502.94 | 1.18 [ High ] | 8,847 | $979,716.78 | 1.89 [Low] | Form 4 | - | 2021-05-12 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 375 | Common Stock | $29.80 | -$11,175.00 | 0.08 [ Very Low ] | 9,222 | $274,815.60 | 1.97 [Low] | Form 4 | - | 2021-05-12 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 231 | Common Stock | $35.98 | -$8,311.38 | 0.05 [ Very Low ] | 9,453 | $340,118.94 | 2.02 [Low] | Form 4 | - | 2021-05-12 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 348 | Common Stock | $16.15 | -$5,620.20 | 0.07 [ Very Low ] | 9,801 | $158,286.15 | 2.09 [Low] | Form 4 | - | 2021-05-17 | Stephen C Farrell | - | Buy | 5,328 | Common Stock | $7.14 | -$38,041.92 | 1.14 [ High ] | 11,136 | $79,511.04 | 2.37 [Low] | Form 4 | - | 2021-05-17 | Stephen C Farrell | - | Sell | 5,328 | Common Stock | $113.87 | $606,699.36 | 1.14 [ High ] | 5,808 | $661,356.96 | 1.24 [Low] | Form 4 | - | 2021-05-19 | Stephen C Farrell | - | Buy | 5,000 | Common Stock | $5.54 | -$27,700.00 | 1.07 [ High ] | 10,808 | $59,876.32 | 2.30 [Low] | Form 4 | - | 2021-05-19 | Stephen C Farrell | - | Sell | 5,000 | Common Stock | $120.00 | $600,000.00 | 1.07 [ High ] | 5,808 | $696,960.00 | 1.24 [Low] | Form 4 | - | 2021-05-21 | Scott D Barnes | Chief Medical Officer | Buy | 2,500 | Common Stock | $16.15 | -$40,375.00 | 0.53 [ Average ] | 25,826 | $417,089.90 | 5.51 [Average] | Form 4 | - | 2021-05-21 | Scott D Barnes | Chief Medical Officer | Buy | 2,229 | Common Stock | $35.98 | -$80,199.42 | 0.48 [ Average ] | 28,055 | $1,009,418.90 | 5.98 [Average] | Form 4 | - | 2021-05-21 | Scott D Barnes | Chief Medical Officer | Buy | 7,566 | Common Stock | $27.53 | -$208,291.98 | 1.61 [ High ] | 35,621 | $980,646.13 | 7.60 [Average] | Form 4 | - | 2021-05-21 | Scott D Barnes | Chief Medical Officer | Sell | 12,295 | Common Stock | $126.05 | $1,549,784.75 | 2.62 [ Very High ] | 23,326 | $2,940,242.30 | 4.97 [Average] | Form 4 | - | 2021-05-21 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 944 | Common Stock | $15.54 | -$14,669.76 | 0.20 [ Low ] | 109,325 | $1,698,910.50 | 23.31 [High] | Form 4 | - | 2021-05-21 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 4,201 | Common Stock | $7.35 | -$30,877.35 | 0.90 [ High ] | 113,526 | $834,416.10 | 24.21 [High] | Form 4 | - | 2021-05-21 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 5,145 | Common Stock | $128.00 | $658,560.00 | 1.10 [ High ] | 108,381 | $13,872,768.00 | 23.11 [High] | Form 4 | - | 2021-05-24 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 25,799 | Common Stock | $7.35 | -$189,622.65 | 5.50 [ Very High ] | 134,180 | $986,223.00 | 28.61 [High] | Form 4 | - | 2021-05-24 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 40,000 | Common Stock | $7.52 | -$300,800.00 | 8.53 [ Very High ] | 174,180 | $1,309,833.60 | 37.14 [High] | Form 4 | - | 2021-05-24 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 22,500 | Common Stock | $9.30 | -$209,250.00 | 4.80 [ Very High ] | 196,680 | $1,829,124.00 | 41.94 [High] | Form 4 | - | 2021-05-24 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 6,556 | Common Stock | $16.15 | -$105,879.40 | 1.40 [ High ] | 203,236 | $3,282,261.40 | 43.34 [High] | Form 4 | - | 2021-05-24 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 94,855 | Common Stock | $130.42 | $12,370,989.10 | 20.23 [ Very High ] | 108,381 | $14,135,050.02 | 23.11 [High] | Form 4 | - | 2021-05-21 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 15,261 | Common Stock | $9.30 | -$141,927.30 | 3.25 [ Very High ] | 67,891 | $631,386.30 | 14.48 [High] | Form 4 | - | 2021-05-21 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 15,261 | Common Stock | $126.83 | $1,935,552.63 | 3.25 [ Very High ] | 52,630 | $6,675,062.90 | 11.22 [Average] | Form 4 | - | 2021-05-24 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 14,500 | Common Stock | $16.15 | -$234,175.00 | 3.09 [ Very High ] | 67,130 | $1,084,149.50 | 14.31 [High] | Form 4 | - | 2021-05-24 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 14,500 | Common Stock | $130.42 | $1,891,090.00 | 3.09 [ Very High ] | 52,630 | $6,864,004.60 | 11.22 [Average] | Form 4 | - | 2021-05-26 | Stephen C Farrell | - | Buy | 5,000 | Common Stock | $7.14 | -$35,700.00 | 1.07 [ High ] | 10,808 | $77,169.12 | 2.30 [Low] | Form 4 | - | 2021-05-26 | Stephen C Farrell | - | Sell | 5,000 | Common Stock | $135.00 | $675,000.00 | 1.07 [ High ] | 5,808 | $784,080.00 | 1.24 [Low] | Form 4 | - | 2021-05-28 | Stephen C Farrell | - | Buy | 5,000 | Common Stock | $5.54 | -$27,700.00 | 1.07 [ High ] | 10,808 | $59,876.32 | 2.30 [Low] | Form 4 | - | 2021-05-28 | Stephen C Farrell | - | Sell | 5,000 | Common Stock | $150.00 | $750,000.00 | 1.07 [ High ] | 5,808 | $871,200.00 | 1.24 [Low] | Form 4 | - | 2021-05-27 | Partners, L.p. Broadwood | - | Sell | 47,571 | Common Stock | $143.42 | $6,822,632.82 | 10.14 [ Very High ] | 9,278,614 | $1,330,738,819.88 | 1,978.59 [Very High] | Form 4 | - | 2021-05-27 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,278,614 | $0.00 | 1,978.59 [Very High] | Form 4 | Footnote | 2021-05-28 | Partners, L.p. Broadwood | - | Sell | 217,693 | Common Stock | $147.43 | $32,094,478.99 | 46.42 [ Very High ] | 9,060,921 | $1,335,851,583.03 | 1,932.17 [Very High] | Form 4 | - | 2021-05-28 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,060,921 | $0.00 | 1,932.17 [Very High] | Form 4 | Footnote | 2021-06-01 | Partners, L.p. Broadwood | - | Sell | 1,014 | Common Stock | $146.36 | $148,409.04 | 0.22 [ Low ] | 9,059,907 | $1,326,007,988.52 | 1,931.96 [Very High] | Form 4 | - | 2021-06-01 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,059,907 | $0.00 | 1,931.96 [Very High] | Form 4 | Footnote | 2021-06-11 | Partners, L.p. Broadwood | - | Sell | 2,275 | Common Stock | $147.05 | $334,538.75 | 0.49 [ Average ] | 9,057,632 | $1,331,924,785.60 | 1,931.47 [Very High] | Form 4 | - | 2021-06-11 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,057,632 | $0.00 | 1,931.47 [Very High] | Form 4 | Footnote | 2021-06-14 | Partners, L.p. Broadwood | - | Sell | 21,895 | Common Stock | $147.79 | $3,235,862.05 | 4.67 [ Very High ] | 9,035,737 | $1,335,391,571.23 | 1,926.80 [Very High] | Form 4 | - | 2021-06-14 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,035,737 | $0.00 | 1,926.80 [Very High] | Form 4 | Footnote | 2021-06-15 | Partners, L.p. Broadwood | - | Sell | 35,380 | Common Stock | $147.46 | $5,217,134.80 | 7.54 [ Very High ] | 9,000,357 | $1,327,192,643.22 | 1,919.26 [Very High] | Form 4 | - | 2021-06-15 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 9,000,357 | $0.00 | 1,919.26 [Very High] | Form 4 | Footnote | 2021-06-16 | Partners, L.p. Broadwood | - | Sell | 30,543 | Common Stock | $148.79 | $4,544,492.97 | 6.51 [ Very High ] | 8,969,814 | $1,334,618,625.06 | 1,912.74 [Very High] | Form 4 | - | 2021-06-16 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 8,969,814 | $0.00 | 1,912.74 [Very High] | Form 4 | See Footnote | 2021-06-17 | Partners, L.p. Broadwood | - | Sell | 63,896 | Common Stock | $150.31 | $9,604,207.76 | 13.63 [ Very High ] | 8,905,918 | $1,338,648,534.58 | 1,899.12 [Very High] | Form 4 | - | 2021-06-17 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 8,905,918 | $0.00 | 1,899.12 [Very High] | Form 4 | See Footnote | 2021-06-18 | Partners, L.p. Broadwood | - | Sell | 13,236 | Common Stock | $152.59 | $2,019,681.24 | 2.82 [ Very High ] | 8,892,682 | $1,356,934,346.38 | 1,896.30 [Very High] | Form 4 | - | 2021-06-18 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 8,892,682 | $0.00 | 1,896.30 [Very High] | Form 4 | See Footnote | 2021-06-24 | Stephen C Farrell | - | Buy | 404 | Common Stock | $0.00 | $0.00 | - | 6,212 | $0.00 | 1.32 [Low] | Form 4 | - | 2021-06-24 | Lou Silverman | - | Buy | 807 | Common Stock | $0.00 | $0.00 | - | 2,924 | $0.00 | 0.62 [Very Low] | Form 4 | - | 2021-06-24 | Gilbert H Kliman | - | Buy | 404 | Common Stock | $0.00 | $0.00 | - | 2,985 | $0.00 | 0.64 [Very Low] | Form 4 | - | 2021-06-24 | K Peony Yu | - | Buy | 404 | Common Stock | $0.00 | $0.00 | - | 722 | $0.00 | 0.15 [Very Low] | Form 4 | - | 2021-06-24 | Thomas G Frinzi | - | Buy | 807 | Common Stock | $0.00 | $0.00 | - | 2,924 | $0.00 | 0.62 [Very Low] | Form 4 | - | 2021-06-24 | Partners, L.p. Broadwood | - | Sell | 67,708 | Common Stock | $157.83 | $10,686,353.64 | 14.44 [ Very High ] | 8,824,974 | $1,392,845,646.42 | 1,881.86 [Very High] | Form 4 | - | 2021-06-24 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 8,824,974 | $0.00 | 1,881.86 [Very High] | Form 4 | Footnote | 2021-06-25 | Partners, L.p. Broadwood | - | Sell | 30,735 | Common Stock | $155.84 | $4,789,742.40 | 6.55 [ Very High ] | 8,794,239 | $1,370,494,205.76 | 1,875.30 [Very High] | Form 4 | - | 2021-06-25 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 8,794,239 | $0.00 | 1,875.30 [Very High] | Form 4 | Footnote | 2021-06-28 | Partners, L.p. Broadwood | - | Sell | 130,000 | Common Stock | $155.19 | $20,174,700.00 | 27.72 [ Very High ] | 8,664,239 | $1,344,603,250.41 | 1,847.58 [Very High] | Form 4 | - | 2021-06-28 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 8,664,239 | $0.00 | 1,847.58 [Very High] | Form 4 | Footnote | 2021-07-01 | Partners, L.p. Broadwood | - | Sell | 655 | Common Stock | $0.00 | $0.00 | - | 8,663,584 | $0.00 | 1,847.44 [Very High] | Form 4 | - | 2021-07-01 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 8,663,584 | $0.00 | 1,847.44 [Very High] | Form 4 | Footnote | 2021-08-10 | Lou Silverman | - | Buy | 10,000 | Common Stock | $9.31 | -$93,100.00 | 2.11 [ High ] | 12,924 | $120,322.44 | 2.73 [Low] | Form 4 | - | 2021-08-10 | Lou Silverman | - | Sell | 10,000 | Common Stock | $145.57 | $1,455,700.00 | 2.11 [ High ] | 2,924 | $425,646.68 | 0.62 [Very Low] | Form 4 | - | 2021-08-10 | Lou Silverman | - | Buy | 10,000 | Common Stock | $8.35 | -$83,500.00 | 2.11 [ High ] | 12,924 | $107,915.40 | 2.73 [Low] | Form 4 | - | 2021-08-10 | Lou Silverman | - | Sell | 10,000 | Common Stock | $145.56 | $1,455,600.00 | 2.11 [ High ] | 2,924 | $425,617.44 | 0.62 [Very Low] | Form 4 | - | 2021-08-10 | Lou Silverman | - | Buy | 9,921 | Common Stock | $9.60 | -$95,241.60 | 2.09 [ High ] | 12,845 | $123,312.00 | 2.71 [Low] | Form 4 | - | 2021-08-10 | Lou Silverman | - | Sell | 9,921 | Common Stock | $145.54 | $1,443,902.34 | 2.09 [ High ] | 2,924 | $425,558.96 | 0.62 [Very Low] | Form 4 | - | 2021-08-10 | Patrick F. Williams | Chief Financial Officer | Buy | 5,121 | Common Stock | $0.00 | $0.00 | - | 33,240 | $0.00 | 7.01 [Average] | Form 4 | - | 2021-08-11 | Patrick F. Williams | Chief Financial Officer | Sell | 2,500 | Common Stock | $140.58 | $351,450.00 | 0.53 [ Average ] | 30,740 | $4,321,429.20 | 6.49 [Average] | Form 4 | - | 2021-08-12 | Samuel J Gesten | Chief Legal Officer | Buy | 6,667 | Common Stock | $16.15 | -$107,672.05 | 1.41 [ High ] | 49,250 | $795,387.50 | 10.39 [Average] | Form 4 | - | 2021-08-12 | Samuel J Gesten | Chief Legal Officer | Buy | 4,495 | Common Stock | $29.80 | -$133,951.00 | 0.95 [ High ] | 53,746 | $1,601,630.80 | 11.34 [Average] | Form 4 | - | 2021-08-12 | Samuel J Gesten | Chief Legal Officer | Buy | 11,364 | Common Stock | $35.98 | -$408,876.72 | 2.40 [ High ] | 65,110 | $2,342,657.80 | 13.74 [Average] | Form 4 | - | 2021-08-12 | Samuel J Gesten | Chief Legal Officer | Buy | 7,156 | Common Stock | $27.53 | -$197,004.68 | 1.51 [ High ] | 72,266 | $1,989,482.98 | 15.25 [High] | Form 4 | - | 2021-08-12 | Samuel J Gesten | Chief Legal Officer | Sell | 29,682 | Common Stock | $134.71 | $3,998,462.22 | 6.26 [ Very High ] | 42,583 | $5,736,355.93 | 8.98 [Average] | Form 4 | - | 2021-08-18 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 5,000 | Common Stock | $7.52 | -$37,600.00 | 1.05 [ High ] | 57,630 | $433,377.60 | 12.16 [Average] | Form 4 | - | 2021-08-18 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 3,664 | Common Stock | $16.15 | -$59,173.60 | 0.77 [ High ] | 61,294 | $989,898.10 | 12.93 [Average] | Form 4 | - | 2021-08-18 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 6,336 | Common Stock | $29.80 | -$188,812.80 | 1.34 [ High ] | 67,630 | $2,015,374.00 | 14.27 [Average] | Form 4 | - | 2021-08-18 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 15,000 | Common Stock | $146.91 | $2,203,650.00 | 3.16 [ Very High ] | 52,630 | $7,731,873.30 | 11.10 [Average] | Form 4 | - | 2021-09-01 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 8,621 | Common Stock | $157.61 | $1,358,755.81 | 1.82 [ High ] | 99,760 | $15,723,173.60 | 21.05 [High] | Form 4 | - | 2021-09-01 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 17,573 | Common Stock | $16.15 | -$283,803.95 | 3.71 [ Very High ] | 117,333 | $1,894,927.95 | 24.76 [High] | Form 4 | - | 2021-09-01 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 17,573 | Common Stock | $157.61 | $2,769,680.53 | 3.71 [ Very High ] | 99,760 | $15,723,173.60 | 21.05 [High] | Form 4 | - | 2021-09-02 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 11,038 | Common Stock | $157.50 | $1,738,485.00 | 2.33 [ High ] | 88,722 | $13,973,715.00 | 18.72 [High] | Form 4 | - | 2021-09-02 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 871 | Common Stock | $16.15 | -$14,066.65 | 0.18 [ Low ] | 89,593 | $1,446,926.95 | 18.90 [High] | Form 4 | - | 2021-09-02 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 13,484 | Common Stock | $29.80 | -$401,823.20 | 2.84 [ Very High ] | 103,077 | $3,071,694.60 | 21.75 [High] | Form 4 | - | 2021-09-02 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 2,988 | Common Stock | $35.98 | -$107,508.24 | 0.63 [ Average ] | 106,065 | $3,816,218.70 | 22.38 [High] | Form 4 | - | 2021-09-02 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 17,343 | Common Stock | $157.50 | $2,731,522.50 | 3.66 [ Very High ] | 88,722 | $13,973,715.00 | 18.72 [High] | Form 4 | - | 2021-09-07 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 11,522 | Common Stock | $157.40 | $1,813,562.80 | 2.43 [ High ] | 77,200 | $12,151,280.00 | 16.29 [High] | Form 4 | - | 2021-09-07 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 14,031 | Common Stock | $35.98 | -$504,835.38 | 2.96 [ Very High ] | 91,231 | $3,282,491.38 | 19.25 [High] | Form 4 | - | 2021-09-07 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 15,100 | Common Stock | $27.53 | -$415,703.00 | 3.19 [ Very High ] | 106,331 | $2,927,292.43 | 22.43 [High] | Form 4 | - | 2021-09-07 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 29,131 | Common Stock | $157.40 | $4,585,219.40 | 6.15 [ Very High ] | 77,200 | $12,151,280.00 | 16.29 [High] | Form 4 | - | 2021-09-16 | Patrick F. Williams | Chief Financial Officer | Sell | 5,121 | Common Stock | $139.38 | $713,764.98 | 1.08 [ High ] | 25,619 | $3,570,776.22 | 5.41 [Average] | Form 4 | - | 2021-10-01 | Partners, L.p. Broadwood | - | Sell | 71,577 | Common Stock | $0.00 | $0.00 | - | 8,592,007 | $0.00 | 1,812.81 [Very High] | Form 4 | - | 2021-10-01 | Partners, L.p. Broadwood | - | Sell | 0 | Common Stock | $0.00 | $0.00 | - | 8,592,007 | $0.00 | 1,812.81 [Very High] | Form 4 | Footnote | 2021-10-04 | Samuel J Gesten | Chief Legal Officer | Sell | 15,000 | Common Stock | $114.53 | $1,717,950.00 | 3.16 [ Very High ] | 27,583 | $3,159,080.99 | 5.82 [Average] | Form 4 | - | 2021-11-16 | Caren L Mason | President & CEO | Buy | 35,000 | Common Stock | $7.76 | -$271,600.00 | 7.35 [ Very High ] | 98,376 | $763,397.76 | 20.67 [High] | Form 4 | - | 2021-11-16 | Caren L Mason | President & CEO | Sell | 35,000 | Common Stock | $114.20 | $3,997,000.00 | 7.35 [ Very High ] | 63,376 | $7,237,539.20 | 13.31 [Average] | Form 4 | - | 2021-11-17 | Caren L Mason | President & CEO | Buy | 35,000 | Common Stock | $7.76 | -$271,600.00 | 7.35 [ Very High ] | 98,376 | $763,397.76 | 20.67 [High] | Form 4 | - | 2021-11-17 | Caren L Mason | President & CEO | Sell | 35,000 | Common Stock | $113.83 | $3,984,050.00 | 7.35 [ Very High ] | 63,376 | $7,214,090.08 | 13.31 [Average] | Form 4 | - | 2021-11-18 | Caren L Mason | President & CEO | Buy | 35,000 | Common Stock | $7.76 | -$271,600.00 | 7.35 [ Very High ] | 98,376 | $763,397.76 | 20.67 [High] | Form 4 | - | 2021-11-18 | Caren L Mason | President & CEO | Sell | 35,000 | Common Stock | $113.83 | $3,984,050.00 | 7.35 [ Very High ] | 63,376 | $7,214,090.08 | 13.31 [Average] | Form 4 | - | 2021-12-14 | Keith Holliday | Chief Technology Officer | Sell | 6,000 | Common Stock | $89.57 | $537,420.00 | 1.26 [ High ] | 16,721 | $1,497,699.97 | 3.51 [Low] | Form 4 | - | 2022-03-07 | Caren L Mason | President & CEO | Buy | 20,269 | Common Stock | $0.00 | $0.00 | - | 83,645 | $0.00 | 17.52 [High] | Form 4 | - | 2022-03-07 | Hans-martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 5,910 | Common Stock | $0.00 | $0.00 | - | 83,110 | $0.00 | 17.40 [High] | Form 4 | - | 2022-03-07 | Samuel J Gesten | Chief Legal Officer | Buy | 7,216 | Common Stock | $0.00 | $0.00 | - | 34,799 | $0.00 | 7.29 [Average] | Form 4 | - | 2022-03-07 | Patrick F. Williams | Chief Financial Officer | Buy | 9,225 | Common Stock | $0.00 | $0.00 | - | 34,844 | $0.00 | 7.30 [Average] | Form 4 | - | 2022-03-07 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 5,839 | Common Stock | $0.00 | $0.00 | - | 58,469 | $0.00 | 12.24 [Average] | Form 4 | - | 2022-03-07 | Keith Holliday | Chief Technology Officer | Buy | 7,716 | Common Stock | $0.00 | $0.00 | - | 24,437 | $0.00 | 5.12 [Average] | Form 4 | - | 2022-03-07 | Scott D Barnes | Chief Medical Officer | Buy | 7,991 | Common Stock | $0.00 | $0.00 | - | 31,317 | $0.00 | 6.56 [Average] | Form 4 | - | 2022-03-14 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 289 | Common Stock | $64.18 | $18,548.02 | 0.06 [ Very Low ] | 58,180 | $3,733,992.40 | 12.18 [Average] | Form 4 | - | 2022-03-21 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 922 | Common Stock | $74.62 | $68,799.64 | 0.19 [ Low ] | 57,258 | $4,272,591.96 | 11.99 [Average] | Form 4 | - | 2022-05-18 | Caren L Mason | President & CEO | Buy | 35,000 | Common Stock | $9.30 | -$325,500.00 | 7.32 [ Very High ] | 118,645 | $1,103,398.50 | 24.82 [High] | Form 4 | - | 2022-05-18 | Caren L Mason | President & CEO | Sell | 35,000 | Common Stock | $56.46 | $1,976,100.00 | 7.32 [ Very High ] | 83,645 | $4,722,596.70 | 17.49 [High] | Form 4 | - | 2022-05-19 | Caren L Mason | President & CEO | Buy | 35,000 | Common Stock | $9.30 | -$325,500.00 | 7.32 [ Very High ] | 118,645 | $1,103,398.50 | 24.82 [High] | Form 4 | - | 2022-05-19 | Caren L Mason | President & CEO | Sell | 35,000 | Common Stock | $57.49 | $2,012,150.00 | 7.32 [ Very High ] | 83,645 | $4,808,751.05 | 17.49 [High] | Form 4 | - | 2022-05-20 | Caren L Mason | President & CEO | Buy | 35,000 | Common Stock | $9.30 | -$325,500.00 | 7.32 [ Very High ] | 118,645 | $1,103,398.50 | 24.82 [High] | Form 4 | - | 2022-05-20 | Caren L Mason | President & CEO | Sell | 35,000 | Common Stock | $58.48 | $2,046,800.00 | 7.32 [ Very High ] | 83,645 | $4,891,559.60 | 17.49 [High] | Form 4 | - | 2022-06-06 | Caren L Mason | President & CEO | Buy | 12,886 | Common Stock | $7.76 | -$99,995.36 | 2.70 [ Very High ] | 96,531 | $749,080.56 | 20.19 [High] | Form 4 | - | 2022-06-06 | Caren L Mason | President & CEO | Buy | 34,928 | Common Stock | $7.52 | -$262,658.56 | 7.31 [ Very High ] | 131,459 | $988,571.68 | 27.50 [High] | Form 4 | - | 2022-06-06 | Caren L Mason | President & CEO | Buy | 14,765 | Common Stock | $9.30 | -$137,314.50 | 3.09 [ Very High ] | 146,224 | $1,359,883.20 | 30.58 [High] | Form 4 | - | 2022-06-06 | Caren L Mason | President & CEO | Buy | 6,191 | Common Stock | $16.15 | -$99,984.65 | 1.29 [ High ] | 152,415 | $2,461,502.25 | 31.88 [High] | Form 4 | - | 2022-06-07 | Patrick F. Williams | Chief Financial Officer | Buy | 5,121 | Common Stock | $0.00 | $0.00 | - | 34,844 | $0.00 | 7.29 [Average] | Form 4 | - | 2022-06-16 | Stephen C Farrell | - | Buy | 355 | Common Stock | $0.00 | $0.00 | - | 6,567 | $0.00 | 1.37 [Low] | Form 4 | - | 2022-06-16 | Gilbert H Kliman | - | Buy | 355 | Common Stock | $0.00 | $0.00 | - | 3,340 | $0.00 | 0.70 [Very Low] | Form 4 | - | 2022-06-16 | Gilbert H Kliman | - | Buy | 2,899 | Common Stock | $0.00 | $0.00 | - | 6,239 | $0.00 | 1.30 [Low] | Form 4 | - | 2022-06-16 | K Peony Yu | - | Buy | 355 | Common Stock | $0.00 | $0.00 | - | 1,077 | $0.00 | 0.23 [Very Low] | Form 4 | - | 2022-06-16 | Thomas G Frinzi | - | Buy | 355 | Common Stock | $0.00 | $0.00 | - | 3,279 | $0.00 | 0.69 [Very Low] | Form 4 | - | 2022-06-16 | Thomas G Frinzi | - | Buy | 1,450 | Common Stock | $0.00 | $0.00 | - | 4,729 | $0.00 | 0.99 [Very Low] | Form 4 | - | 2022-06-16 | Elizabeth Yeu Lin | - | Buy | 355 | Common Stock | $0.00 | $0.00 | - | 355 | $0.00 | 0.07 [Very Low] | Form 4 | - |
